Medical Devices US

US Anti-Snoring Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Anti-Snoring Devices Market Analysis Industry Trends and Forecast to 2034: Segmented by (By Device Type, By End User, By Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034F

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $560.7 Mn Placeholder estimate
Estimate 2025 $598.8 Mn 40.5% of the global market
Projected 2034 $1.08 Bn 80.8% Adds $483.7 Mn over 9 forecast years
CAGR 2025–2034 6.8% Faster than 50% of 173 Medical Devices markets here
Key players 6 +1
  • US is 40.47% of the global market.
  • In North America, the largest is US (this report) at $598.8 Mn.
  • Fastest growing: Canada at 8.8% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$483.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Anti-Snoring Devices Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $560.7 Mn — —
2025 (base) $598.8 Mn +$38.1 Mn —
2026 (forecast) $639.5 Mn +$40.7 Mn +6.8%
2027 (forecast) $683.0 Mn +$43.5 Mn +14.1%
2028 (forecast) $729.5 Mn +$46.4 Mn +21.8%
2029 (forecast) $779.1 Mn +$49.6 Mn +30.1%
2030 (forecast) $832.1 Mn +$53.0 Mn +38.9%
2031 (forecast) $888.6 Mn +$56.6 Mn +48.4%
2032 (forecast) $949.1 Mn +$60.4 Mn +58.5%
2033 (forecast) $1.01 Bn +$64.5 Mn +69.3%
2034 (forecast) $1.08 Bn +$68.9 Mn +80.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Anti-Snoring Devices Market Analysis at a glance
Market size, 2025$598.8 Mn placeholder estimate
Forecast, 2034$1.08 Bn placeholder estimate
Growth (CAGR), 2025–20346.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDevice type and end user (see all)
Key playersResMed Inc., Koninklijke Philips N.V., SomnoMed, Fisher & Paykel, Apnea Sciences and 1 more (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
Active clinical trials88 in the USSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Anti-Snoring Devices Market Executive Summary

Approximately 25% to 50% of adults snore regularly, with about 90 Mn Americans reporting snoring at some point in their lives, and 37 Mn stating they snore regularly. It stems from the inflammation of tissues in the upper airway and causes life-threatening risks such as cardiovascular disease and diabetes. Positional devices, oral appliances, positional aids, and continuous positive airway pressure (CPAP) treatments provide relief by enhancing airflow and avoiding blockage of airways during sleeping.

The market for the anti-snoring device has been growing because of growing awareness of sleep disorders, increasing obesity rates, and the growing elderly population. There is a growing popularity in both invasive and non-invasive treatment options, which include nasal devices, mandibular advancement devices, CPAP machines, and smart wearables. North America is the largest market for injectable drugs followed by Europe and Asia-Pacific, primarily due to increasing accessibility and understanding of healthcare requirements in emerging nations like China and India. Market growth is supported by technology development and new product development.

Bar chart: US Anti-Snoring Devices market size, 2024–2034, placeholder estimates. $560.7 Mn in 2024, $598.8 Mn in 2025 and $1.08 Bn in 2034, 6.8% CAGR.
US Anti-Snoring Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Anti-Snoring Devices Market Dynamics

Market Growth Drivers

The market of anti-snoring devices is advancing because of increase in the incidence of snoring problems like obstructive sleep apnea due to obesity and increased life span. Awareness of the relative risks to health and greater comfort and convenience offered by technological advancements in devices are other factors that are driving the demand. On the same note, a rising elderly and overweight population, coupled with rising healthcare expenditure and promotional campaigns on health, is leading to the continued growth of the market.

Opportunity

The markets with future development opportunities in the anti-snoring devices market are the Asia-Pacific and Latin American markets, which are experiencing enhancements in healthcare systems and a rise in awareness of this condition. Smart features like smart sensors, wireless solutions, and tailored functions will improve device desirability and performance.

Market Restraints

Some of the challenges affecting the anti-snoring devices market are discomfort among the users, high prices especially where the devices have to be custom made, and questions of inefficiency and lack of adequate scientific evidence. Lack of acceptance related to snoring and competition from related products such as CPAP machines and surgeries also pose as constraints to market growth. Moreover, in areas that are not very exposed to health promotion and awareness campaigns, gaps in knowledge deter demand.

Competitive Landscape for Anti-Snoring Devices Market in US

Key Players

Recent Developments

December 2025, For the first time, the FDA cleared oral devices that treat severe obstructive sleep apnea (OSA). These devices offer an alternative to more common sleep apnea treatments, like continuous positive airway pressure (CPAP) therapy and surgery.

November 2022, Prosomnus announced Nov. 2, 2022, that it received FDA 510(k) clearance for its ProSomnus EVO [PH] sleep and snore device, a precision oral appliance therapy (OAT) device.

February 2021, The FDA authorized marketing of a new prescription device, eXciteOSA, to reduce snoring and mild obstructive sleep apnea. It is the first device used while awake that is intended to improve tongue muscle function, which in time can help prevent the tongue from collapsing backwards and obstructing the airway during sleep.

Mergers and Acquisitions

July 2024, EnsoData announces the acquisition of sleep testing diagnostic technology from Resonea aimed at reducing the cost of systematically addressing sleep apnea across large patient populations. With this acquisition, EnsoData adds acoustic flow and microphone data channels to enable an exciting new way to pre-screen patients for sleep apnea with an FDA-cleared mobile application and extend the diagnostic capabilities of home sleep testing.

Healthcare Policies and Regulatory Landscape for Anti-Snoring Devices Market in US

Anti-Snoring Devices in the US: rules, payment and research

The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2] ClinicalTrials.gov lists 88 studies on Anti-Snoring Devices that are recruiting, active or about to start in the US.⁠[3]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.

Policy changes and Reimbursement scenario

Regulatory shifts and favourable healthcare campaigns are fostering the use of anti-snoring devices because sleep disorders, including snoring, and OSA are significant concerns. The deregulation of the approval systems and emphasis placed on minimally invasive procedures are positively influencing the development of new products and market participation. The role of reimbursement scenarios is prominent in the context to insurance coverage in regions involving North America that escalates the adoption. An emerging market is present as existing potential markets can progress over time, and this is also applicable to healthcare systems that can improve the access and reimbursement of anti-snoring treatments.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Anti-Snoring Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 9 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Anti-Snoring Devices in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 16 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Anti-Snoring Devices market in the US?
Placeholder estimate: about $598.8 Mn in 2025, rising to about $1.08 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Anti-Snoring Devices market in the US growing?
Placeholder estimate: about 6.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Anti-Snoring Devices market report cover?
The report splits the market by device type (Oral Appliances/Mouthpieces, Nasal Devices, Position Control Devices, Chin Straps and more) and end user (Hospitals, Ambulatory Surgical Centres (ASCs), Specialty Clinics, Home Care Settings).
Who are the key players in the Anti-Snoring Devices market?
Key players include ResMed Inc., Koninklijke Philips N.V., SomnoMed, Fisher & Paykel, Apnea Sciences and Tomed.
What is driving the Anti-Snoring Devices market?
The market of anti-snoring devices is advancing because of increase in the incidence of snoring problems like obstructive sleep apnea due to obesity and increased life span.
Who regulates Anti-Snoring Devices in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How many clinical trials on Anti-Snoring Devices are running in the US?
88 studies are recruiting, active or about to start in the US, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 9 Nov 2026.
How much research is published on Anti-Snoring Devices?
PubMed lists 2,051 papers on Anti-Snoring Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 9 Nov 2026.
Back to Catalogue

Related Medical Devices reports in US

See all

Related on sleep and respiratory

See the topic